Marijuana acts on the central nervous system mainly through CB1 cannabinoid receptors in the brain and spinal cord, which is why THC changes memory, movement, mood, appetite, pain and body temperature. Research supports a few medical uses tied to the nervous system, such as an FDA-approved CBD drug for two rare forms of epilepsy and relief of MS spasticity symptoms, while evidence for most other neurological conditions is limited or missing.
The central nervous system (CNS) is the brain and spinal cord, the command center that controls thought, movement and sensation. Cannabis has an unusually direct line into it because the CNS runs its own cannabis-like signaling network, the endocannabinoid system. This article explains how that system works, what animal and human studies show about cannabis and the CNS, and where the medical evidence stands in 2026.
Evidence at a Glance
| Claim | Evidence level | Source |
|---|---|---|
| Oral cannabinoids improve patient-reported MS spasticity | Substantial | National Academies, 2017 |
| Cannabis or cannabinoids treat chronic pain in adults | Substantial, with small benefits in recent reviews | National Academies; Wang et al., BMJ, 2021 |
| Purified CBD (Epidiolex) reduces seizures in Lennox-Gastaut and Dravet syndromes | Strong; FDA approved | FDA |
| Cannabinoids improve short-term sleep in some conditions | Moderate | National Academies |
| Cannabinoids help Tourette syndrome symptoms | Limited | National Academies |
| Cannabinoids help Parkinson’s, ALS, Huntington’s or dystonia | No or insufficient evidence | National Academies |
| Cannabinoids improve dementia symptoms | Limited evidence they are ineffective | National Academies |
| Cannabis use raises the risk of schizophrenia and other psychoses | Substantial | National Academies |
The Endocannabinoid System in the CNS
The body makes its own cannabinoids, mainly anandamide and 2-AG, and two main receptors respond to them. A review in the International Journal of Molecular Sciences describes CB1 as the prominent cannabinoid receptor in the central nervous system. The National Cancer Institute adds that CB1 is also found on peripheral nerve endings and is increased in pain-processing regions, while CB2 sits mainly in immune cells, with very low levels in the CNS.
NCI lists the system’s jobs as pain modulation, control of movement, feeding, mood, inflammation, neuroprotection and memory. In practice, endocannabinoids act as a brake that fine-tunes how strongly nerve cells signal each other. THC presses on that brake everywhere at once. For a step-by-step look at the brain side, read how THC affects the brain.
One notable gap
Cannabinoid receptors are scarce in one critical place. NCI explains that, unlike opioid receptors, they are not located in the brainstem areas that control breathing, which is why lethal cannabis overdoses do not occur. Overconsumption can still cause panic, vomiting, a racing heart and emergency visits.
What Animal Studies Revealed
Much of what we know about cannabis and the CNS came from animals. The study that first ran on this page was a 1999 Oxford commentary on mouse research. In the key experiment, NIH scientists bred mice without the CB1 gene. In normal mice, THC produces a classic set of effects: frozen immobility (catalepsy), reduced movement and lower body temperature. In the mice lacking CB1, those THC effects were completely absent, proving that CB1 drives them. Some pain-relieving effects remained, hinting that other pathways are involved.
The same mice moved less, felt pain differently and died at higher rates than normal mice, showing that the endocannabinoid system matters for basic nervous system function even without cannabis. As with all animal research, these findings explain mechanisms but do not translate directly to people.
How Cannabis Affects the Human CNS
Short-term effects
NIDA lists the short-term effects as altered time perception and impaired thinking, memory and body movement, along with irritability or restlessness in some people. The National Academies found moderate evidence that acute use impairs learning, memory and attention. Reaction time and coordination suffer as well; our article on cannabis, motor function and pain sensitivity covers those effects in detail.
Long-term effects
Regular heavy use leads the brain to reduce its CB1 receptors, a change that reversed after about four weeks of abstinence in a PET imaging study. Heavy use that begins in adolescence is linked to changes in brain structure and small cognitive deficits; see our reviews of brain damage studies and IQ studies.
Cannabis and Neurological Conditions
Epilepsy
The FDA approved Epidiolex, a purified CBD medicine, for seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. The National Academies’ 2017 report rated evidence for cannabinoids in epilepsy as insufficient, but it was written before Epidiolex’s approval in 2018. Dispensary CBD and THC products are not the same as the prescription drug and are not approved for seizures.
Multiple sclerosis
The National Academies found substantial evidence that oral cannabinoids improve patient-reported MS spasticity, but only limited evidence for improvements measured by clinicians. That gap suggests patients feel better even when exam findings change less.
Chronic and nerve pain
The National Academies rated cannabis for chronic pain in adults as substantial. Later reviews show the benefit is modest. A 2021 BMJ meta-analysis of 32 trials found non-inhaled medical cannabis produced small to very small improvements in pain, physical functioning and sleep, with transient side effects. For nerve pain specifically, a 2026 Cochrane update of 21 trials found no clear evidence that THC-dominant medicines produce 50% pain relief, with more nervous system side effects.
Other conditions
Evidence is limited for Tourette syndrome and moderate for short-term sleep improvement in people with sleep problems tied to conditions such as chronic pain, MS and fibromyalgia. For Parkinson’s disease, ALS, Huntington’s disease and dystonia, the National Academies found no or insufficient evidence, and for dementia symptoms it found limited evidence that cannabinoids do not help.
Risks and Side Effects
- Dizziness, drowsiness and impaired attention: common in medical trials; the BMJ review found dizziness risk rose in trials lasting three months or more.
- Psychosis: substantial evidence links cannabis use to schizophrenia and other psychoses, highest in the most frequent users.
- Driving: substantial evidence links cannabis use to motor vehicle crashes.
- Dependence: about 2 to 3 in 10 users develop cannabis use disorder.
- Developing brains: the CDC notes the brain develops until about age 25 and use before 18 may affect how it builds connections.
Talk to Your Doctor
If you have epilepsy, MS, chronic pain or another neurological condition, talk to your neurologist before trying cannabis. Cannabinoids can interact with seizure medicines, sedatives and antidepressants, and the prescription options, Epidiolex, dronabinol and nabilone, come with known doses and quality controls that dispensary products lack.
Marijuana and the Central Nervous System FAQ
Is marijuana a depressant or a stimulant?
Neither label fits well. Cannabis can relax and sedate some people, stimulate appetite, or at high doses cause anxiety and paranoia. It acts through its own receptor system, CB1, rather than the pathways used by classic depressants or stimulants.
How does THC affect the central nervous system?
THC activates CB1 receptors in the brain and spinal cord, changing memory, attention, coordination, mood, appetite, pain perception and body temperature for several hours.
Can marijuana damage the nervous system?
There is no evidence that typical use causes nerve damage. Heavy use, especially starting in the teens, is linked to brain changes and small memory deficits, and some changes reverse with abstinence.
Does CBD affect the central nervous system?
Yes, but differently from THC. CBD does not produce a high. Purified prescription CBD is FDA approved for seizures in Lennox-Gastaut and Dravet syndromes.
Does marijuana help multiple sclerosis?
Oral cannabinoids improve spasticity symptoms that patients report, according to substantial evidence reviewed by the National Academies. Clinician-measured improvement is less clear.
More explainers are in our Cannabis Health & Research section.
For adults 21+ in legal states. General information, not medical advice. Talk to a doctor before using cannabis for a health condition.
